Minireviews
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 14, 2016; 22(34): 7727-7734
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7727
Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article
Che-Yung Chao, Robert Battat, Alex Al Khoury, Sophie Restellini, Giada Sebastiani, Talat Bessissow
Che-Yung Chao, Robert Battat, Alex Al Khoury, Giada Sebastiani, Talat Bessissow, Division of Gastroenterology, McGill University Health Center, Montreal, QC H3G 1A4, Canada
Sophie Restellini, Division of Gastroenterology and Hepatology, Geneva’s University Hospitals and University of Geneva, 1205 Genève, Switzerland
Author contributions: All co-authors have contributed equally to this article.
Conflict-of-interest statement: Sebastiani G has acted as speaker for Merck, Abbvie, Gilead, BMS served as an advisory board member for Merck, BMS and has received research funding from ViiV and Merck; Bessissow T has received honoraria and acted as a consultant for Janssen, AbbVie, Takeda, Ferring, Actavis and Shire; other co-authors have no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Talat Bessissow, MD, FRCPC, Division of Gastroenterology, McGill University Health Center, 1650 Avenue Cedar C7-200, Montreal, QC H3G 1A4, Canada. talat.bessissow@mcgill.ca
Telephone: +1-514-9341934 Fax: +1-514-9348531
Received: March 14, 2016
Peer-review started: March 15, 2016
First decision: April 14, 2016
Revised: June 19, 2016
Accepted: July 31, 2016
Article in press: August 1, 2016
Published online: September 14, 2016
Processing time: 178 Days and 5 Hours
Core Tip

Core tip: This article reviews the current available literature on issues relating to the co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease with particular focus on the prevalence, risk factors and the clinical implications.